These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9888792)

  • 1. Probing the interaction between a high-affinity single-chain Fv and a pyrimidine (6-4) pyrimidone photodimer by site-directed mutagenesis.
    Kobayashi H; Morioka H; Tobisawa K; Torizawa T; Kato K; Shimada I; Nikaido O; Stewart JD; Ohtsuka E
    Biochemistry; 1999 Jan; 38(2):532-9. PubMed ID: 9888792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
    Tan PH; Sandmaier BM; Stayton PS
    Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Framework residues 71 and 93 of the chimeric B72.3 antibody are major determinants of the conformation of heavy-chain hypervariable loops.
    Xiang J; Sha Y; Jia Z; Prasad L; Delbaere LT
    J Mol Biol; 1995 Oct; 253(3):385-90. PubMed ID: 7473721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies specific for (6-4) DNA photoproducts: cloning, antibody modeling and construction of a single-chain Fv derivative.
    Morioka H; Miura H; Kobayashi H; Koizumi T; Fujii K; Asano K; Matsunaga T; Nikaido O; Stewart JD; Ohtsuka E
    Biochim Biophys Acta; 1998 Jun; 1385(1):17-32. PubMed ID: 9630483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
    Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
    Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
    Chen Y; Stollar BD
    J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Domain interactions and antigen binding of recombinant anti-Z-DNA antibody variable domains. The role of heavy and light chains measured by surface plasmon resonance.
    Polymenis M; Stollar BD
    J Immunol; 1995 Mar; 154(5):2198-208. PubMed ID: 7868893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational multiplicity of the antibody combining site of a monoclonal antibody specific for a (6-4) photoproduct.
    Torizawa T; Kato K; Kato J; Kobayashi H; Komatsu Y; Morioka H; Nikaido O; Ohtsuka E; Shimada I
    J Mol Biol; 1999 Jul; 290(3):731-40. PubMed ID: 10395826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The specificity properties that distinguish members of a set of homologous anti-digoxin antibodies are controlled by H chain mutations.
    Near RI; Bruccoleri R; Novotny J; Hudson NW; White A; Mudgett-Hunter M
    J Immunol; 1991 Jan; 146(2):627-33. PubMed ID: 1898959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical interactions in binding antibody NC41 to influenza N9 neuraminidase: amino acid contacts on the antibody heavy chain.
    Pruett PS; Air GM
    Biochemistry; 1998 Jul; 37(30):10660-70. PubMed ID: 9692956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
    Wu H; Nie Y; Huse WD; Watkins JD
    J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
    Chatellier J; Van Regenmortel MH; Vernet T; Altschuh D
    J Mol Biol; 1996 Nov; 264(1):1-6. PubMed ID: 8950262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Construction and expression of single chain Fv antibody against human bladder carcinoma].
    Zhang M; Yu L; Huang H
    Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):792-5. PubMed ID: 16201198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stabilization and humanization of a single-chain Fv antibody fragment specific for human lymphocyte antigen CD19 by designed point mutations and CDR-grafting onto a human framework.
    Kügler M; Stein C; Schwenkert M; Saul D; Vockentanz L; Huber T; Wetzel SK; Scholz O; Plückthun A; Honegger A; Fey GH
    Protein Eng Des Sel; 2009 Mar; 22(3):135-47. PubMed ID: 19188138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene cloning, bacterial expression, in vitro refolding, and characterization of a single-chain Fv antibody against PreS1(21-47) fragment of HBsAg.
    Yang X; Hu W; Li F; Xia H; Zhang Z
    Protein Expr Purif; 2005 Jun; 41(2):341-8. PubMed ID: 15866720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humanization by variable domain resurfacing and grafting on a human IgG4, using a new approach for determination of non-human like surface accessible framework residues based on homology modelling of variable domains.
    Staelens S; Desmet J; Ngo TH; Vauterin S; Pareyn I; Barbeaux P; Van Rompaey I; Stassen JM; Deckmyn H; Vanhoorelbeke K
    Mol Immunol; 2006 Mar; 43(8):1243-57. PubMed ID: 16118019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
    van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
    J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
    Wörn A; Plückthun A
    Biochemistry; 1998 Sep; 37(38):13120-7. PubMed ID: 9748318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of avidity and fine specificity of anti-levan antibodies.
    Brorson K; Thompson C; Wei G; Krasnokutsky M; Stein KE
    J Immunol; 1999 Dec; 163(12):6694-701. PubMed ID: 10586066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.